Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, January 23, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
Life Sciences Times
-
December 16, 2024
Pharma
Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550
Life Sciences Times
-
December 2, 2024
Pharma
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B
Life Sciences Times
-
November 15, 2024
Pharma
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Life Sciences Times
-
November 7, 2024
Pharma
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
Life Sciences Times
-
October 30, 2024
Pharma
Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares
Life Sciences Times
-
January 30, 2023
0
Pharma
Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging
Life Sciences Times
-
January 30, 2023
0
Pharma
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and...
Life Sciences Times
-
January 27, 2023
0
Pharma
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Life Sciences Times
-
January 27, 2023
0
Pharma
BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA
Life Sciences Times
-
January 19, 2023
0
Pharma
Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm
Life Sciences Times
-
January 17, 2023
0
Pharma
Lantern Pharma Receives Pre-IND Feedback from the FDA, Clearing a Path for Drug Candidate LP-184’s Phase 1 Clinical Trial in Q2 2023
Life Sciences Times
-
January 17, 2023
0
Pharma
Results of the First Post-Commercial Utilization Review of JELMYTO® Provide New Evidence that Reinforces its Efficacy and Safety in Patients with Low-Grade Upper Tract...
Life Sciences Times
-
January 11, 2023
0
Pharma
Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer
Life Sciences Times
-
January 10, 2023
0
Pharma
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon...
Life Sciences Times
-
January 10, 2023
0
Pharma
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603
Life Sciences Times
-
January 9, 2023
0
Pharma
Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease
Life Sciences Times
-
January 9, 2023
0
1
...
11
12
13
...
59
Page 12 of 59
Most Read
Timothy G. Ferris, MD, MPH, Former NHS England and Mass General Executive, Joins Red Cell Partners to Lead Healthcare Practice
January 21, 2025
Devonian Appoints Viktoria Krasteva as Chief Financial Officer
January 21, 2025
Wedgewood Appoints Benjamin Daniels as General Counsel and Chief Compliance Officer
January 21, 2025
Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility
January 21, 2025